Scilex Holding Co - Warrants (10/11/2027

(Warrants)
0
NAS:SCLXW (USA)   Warrants (10/11/2027)
$ 0.29 -0.001 (-0.34%) 10:06 AM EST
Volume:
753.00
Avg Vol (2M):
-
Trade In:

Business Description

Scilex Holding Co
NAICS : 325411 SIC : 2834

Share Class Description:

SCLXW: Warrants (10/11/2027)
Description
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
Name Current Vs Industry Vs History
Cash-To-Debt 0.06
Equity-to-Asset -2.05
Debt-to-Equity -0.5
Debt-to-EBITDA -0.95
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -12.7
Distress
Grey
Safe
Beneish M-Score -7.97
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.2
Quick Ratio 0.19
Cash Ratio 0.03
Days Inventory 80.61
Days Sales Outstanding 210.12
Days Payable 763.92

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio 9.1
Shareholder Yield % -94.51
Name Current Vs Industry Vs History
Gross Margin % 68.24
Operating Margin % -195.02
Net Margin % -233.88
ROA % -117.92
ROIC % -70.12
3-Year ROIIC % -92.63
ROC (Joel Greenblatt) % -3174.85

GF Value Rank

Name Current Vs Industry Vs History
PE Ratio N/A
N/A
N/A
PE Ratio without NRI N/A
N/A
N/A
PS Ratio 2.13
Price-to-Free-Cash-Flow 10.17
Price-to-Operating-Cash-Flow 9.86
EV-to-FCF 19.27
FCF Yield % 8.47

Financials (Next Earnings Date:2024-11-14 Est.)

SCLXW's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:SCLXW

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Scilex Holding Co Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) 0
Beta 0
Volatility % 0
14-Day RSI 0
14-Day ATR ($) 0
20-Day SMA ($) 0
12-1 Month Momentum % 0
52-Week Range ($) 0 - 4.5
Shares Outstanding (Mil)

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Scilex Holding Co Filings

Filing Date Document Date Form
No Filing Data

Scilex Holding Co Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Scilex Holding Co Frequently Asked Questions

What is Scilex Holding Co(SCLXW)'s stock price today?
The current price of SCLXW is $0.29. The 52 week high of SCLXW is $4.50 and 52 week low is $0.00.
When is next earnings date of Scilex Holding Co(SCLXW)?
The next earnings date of Scilex Holding Co(SCLXW) is 2024-11-14 Est..
Does Scilex Holding Co(SCLXW) pay dividends? If so, how much?
Scilex Holding Co(SCLXW) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1